COHANCE LIFESCIENCES
Sector : Pharmaceuticals and health care | Midcap | BSE
Here's the live share price of Cohance Lifesciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-2.28₹ -22.6
As on Sep 17, 2025, 4:01 PM IST
Cohance Lifesciences Price Performance
Today's LowToday's High
₹962.45₹994.75
₹967.00
52 Weeks' Low52 Weeks' High
₹856.90₹1,359.00
₹967.00
Open Price
₹985.00
Prev. Close
₹989.60
Volume
3,652
Over the last 5 years, the share price of Cohance Lifesciences has gained 20.30% CAGR. Over the past year, the corresponding return has been -16.33%.
Cohance Lifesciences’s current P/E of 144.52x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Stocks with good 1 month returns Screener.
Cohance Lifesciences Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Cohance Lifesciences | -2.30 | 7.56 | -2.57 | -14.86 | -16.33 | 28.11 | 20.30 |
| Sun Pharmaceutical Industries | 1.67 | -0.74 | -1.73 | -5.03 | -13.17 | 22.82 | 25.92 |
| Divi's Laboratories | 0.43 | -1.79 | -7.35 | 6.82 | 11.03 | 18.72 | 13.53 |
| Cipla | -0.28 | -0.33 | 3.71 | 4.44 | -6.69 | 14.64 | 15.70 |
| Torrent Pharmaceuticals | -1.10 | -2.72 | 9.28 | 16.13 | 2.96 | 33.93 | 20.15 |
| Dr. Reddy's Laboratories | 0.52 | 3.73 | -0.61 | 13.95 | -1.15 | 16.94 | 6.31 |
| Mankind Pharma | -1.64 | 3.88 | 9.08 | 18.13 | 4.58 | 21.69 | 12.50 |
| Zydus Lifesciences | -0.57 | 4.75 | 7.77 | 15.69 | -6.93 | 42.16 | 21.26 |
| Lupin | 2.60 | 3.02 | 4.40 | 1.91 | -10.64 | 46.79 | 14.35 |
| Abbott India | -0.85 | -4.90 | -2.43 | 2.84 | 7.47 | 21.30 | 13.54 |
| Alkem Laboratories | 2.66 | 2.12 | 13.49 | 13.40 | -12.19 | 18.95 | 13.98 |
| Aurobindo Pharma | 4.16 | 0.37 | -1.39 | -1.69 | -29.51 | 28.16 | 6.17 |
| Glenmark Pharmaceuticals | -4.41 | 3.19 | 23.20 | 42.38 | 18.91 | 76.49 | 32.85 |
| Anthem Biosciences | 5.89 | 7.84 | 18.23 | 18.23 | 18.23 | 5.74 | 3.41 |
| Laurus Labs | -0.51 | 3.09 | 35.04 | 53.43 | 77.96 | 20.69 | 25.98 |
| Biocon | -2.53 | -2.59 | 0.62 | 6.24 | -5.53 | 6.94 | -4.31 |
| GlaxoSmithKline Pharmaceuticals | -3.46 | -1.94 | -15.89 | 1.60 | -2.30 | 24.69 | 9.19 |
| Ipca Laboratories | -0.07 | -5.18 | -3.23 | -0.19 | -9.85 | 15.26 | 4.10 |
| Gland Pharma | 4.39 | 0.78 | 13.75 | 27.92 | 7.57 | -3.99 | 1.77 |
| Ajanta Pharma | -1.46 | -4.97 | 0.37 | -0.75 | -18.86 | 26.28 | 20.00 |
Over the last one year, Cohance Lifesciences has declined 16.33% compared to peers like Sun Pharmaceutical Industries (-13.17%), Divi's Laboratories (11.03%), Cipla (-6.69%). From a 5 year perspective, Cohance Lifesciences has outperformed peers relative to Sun Pharmaceutical Industries (25.92%) and Divi's Laboratories (13.53%).
Cohance Lifesciences Financials
Cohance Lifesciences Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 994.11 | 984.99 |
| 10 | 961.84 | 970.84 |
| 20 | 927.26 | 956.14 |
| 50 | 973.02 | 968.1 |
| 100 | 1,011.63 | 1,003.33 |
| 200 | 1,080.34 | 1,025.28 |
Cohance Lifesciences Share Holding Pattern
In the latest quarter, Cohance Lifesciences remained same as its previous close in promoter holding, while DII stake increased to 11.40%, FII holding fell to 7.23%, and public shareholding moved down to 14.95% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Cohance Lifesciences Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| DSP Healthcare Fund | 26,02,612 | 7.38 | 229.19 |
| Invesco India Contra Fund | 21,73,352 | 1.01 | 191.39 |
| Axis Small Cap Fund | 20,26,449 | 0.7 | 178.45 |
| DSP ELSS Tax Saver Fund | 19,10,066 | 1.02 | 168.2 |
| DSP Flexi Cap Fund | 18,30,535 | 1.38 | 161.2 |
| UTI Flexi Cap Fund | 17,69,562 | 0.61 | 155.83 |
| Canara Robeco Small Cap Fund | 15,74,180 | 1.1 | 138.62 |
| 360 ONE Focused Equity Fund | 15,66,573 | 1.9 | 137.95 |
| DSP Equity Opportunities Fund | 14,67,138 | 0.84 | 129.2 |
| DSP Equity & Bond Fund | 13,85,104 | 1.08 | 121.97 |
Cohance Lifesciences Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 15, 2025, 8:47 PM IST | Cohance Lifesciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Sep 11, 2025, 11:39 PM IST | Cohance Lifesciences - Completion Of USFDA Inspection |
| Sep 07, 2025, 11:08 PM IST | Cohance Lifesciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Aug 28, 2025, 9:43 PM IST | Cohance Lifesciences - Letter To Shareholders Regarding Annual Report |
| Aug 27, 2025, 10:23 PM IST | Cohance Lifesciences - General Announcement |
About Cohance Lifesciences
Cohance Lifesciences Ltd. is a Public Limited Listed company incorporated on 06/11/2018 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24299MH2018PLC422236 and registration number is 422236. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company's Total Operating Revenue is Rs. 1093.51 Cr. and Equity Capital is Rs. 25.46 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address215 Atrium, C Wing, 8th Floor, Mumbai Maharashtra 400093
- Contact
Management
- Mr. Vivek SharmaExecutive Chairman
- Dr. V Prasada RajuManaging Director
- Mr. Pankaj PatwariNon Executive Director
- Ms. Shweta JalanNon Executive Director
- Mr. Vinod PadikkalNon Executive Director
- Mr. Vinod RaoIndependent Director
- Mr. K G AnanthakrishnanIndependent Director
- Mr. U B Pravin RaoIndependent Director
- Ms. Matangi GowrishankarIndependent Director
- Mr. Jai Shankar KrishnanIndependent Director
FAQs on Cohance Lifesciences Share Price
What is the share price of Cohance Lifesciences?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Cohance Lifesciences is ₹967.00 as on Sep 17, 2025.
What kind of stock is Cohance Lifesciences?
The Cohance Lifesciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
What is the Market Cap of Cohance Lifesciences?
The market cap of Cohance Lifesciences is ₹36,994.24 Cr as on Sep 17, 2025.
What are today's High and Low prices of Cohance Lifesciences?
Today’s highest and lowest price of Cohance Lifesciences are ₹994.75 and ₹962.45.
What are the 52 Week High and 52 Week Low of Cohance Lifesciences?
The 52-week high/low is the highest and lowest price at which Cohance Lifesciences stock has traded in the past 52-week or nearly a year. The 52-week high of Cohance Lifesciences is ₹1,359.00 and 52-week low of Cohance Lifesciences is ₹856.90 as on Sep 17, 2025.
How has the Cohance Lifesciences performed historically in terms of returns?
The Cohance Lifesciences has shown returns of -2.28% over the past day, 7.56% for the past month, -2.57% over 3 months, -16.33% over 1 year, 28.11% across 3 years, and 20.3% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Cohance Lifesciences?
P/E ratio of and PB ratio of Cohance Lifesciences are 144.52 and 21.64 on Sep 17, 2025. While the company gives a dividend yield of 0.00 per annum.
Trending In Market
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data